Loading...
Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
Systemic treatment with the active transcription inhibitor lurbinectedin aims at inducing tumor cell death in hyperproliferative neoplasms. Here we show that cell death induced by lurbinectedin reinstates and enhances systemic anticancer immune responses. Lurbinectedin treatment showed traits of imm...
Na minha lista:
| Udgivet i: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791417/ https://ncbi.nlm.nih.gov/pubmed/31646106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1656502 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|